UHC’s right: musculoskeletal disorders (MSDs) are one of the biggest cost drivers in healthcare today. But knowing that—and doing something meaningful about it—are two very different things.

Here’s the truth: the insurance industry isn’t built to solve your MSD problem. In fact, it profits when it doesn’t.

Back pain, joint degeneration, repetitive strain, poor posture—these aren’t just medical issues. They’re operational liabilities. Quietly draining productivity. Silently inflating claims. Predictably showing up in your renewal rates.

And yet, the dominant response from BUCAH carriers (Blue Cross, UnitedHealthcare, Cigna, Aetna, Humana) is not to eliminate the cost. It’s to manage it.

Because under current models, rising utilization means rising revenue. Premiums are priced on expected spend—plus margin. So when more employees need imaging, prescriptions, and specialist referrals, insurers don’t lose. They earn.

That’s not a bug. That’s the business model.

This is the incentive gap. And it’s costing you.

MSD cost reduction doesn’t start at surgery. It doesn’t even start at rehab.

It starts before the pain becomes a claim.

Solveglobal delivers a functional-first, performance-driven model that rewires how musculoskeletal health is delivered and valued—detecting risk early, reducing friction, and restoring capability before cost spirals out of control.

But today’s benefit designs do the opposite. They delay care with visit caps, narrow networks, prior authorizations, and confusing policies. The result? Employees bounce from one expensive intervention to the next—when early, conservative care would have worked better and cost less.

Insurers call this “managing spend.” Employers and employees call it what it is: a frustrating, avoidable waste.

Worse, reporting reinforces the reactive cycle. Carriers show you where the dollars went—but never why care came so late, or how plan design made it inevitable.

If insurers were truly incentivized to solve MSDs, you’d see it in the plan design: more coverage for therapy, fewer administrative traps, smarter partnerships aligned to outcomes—not volume.

MSDs are a known cost driver. The deeper issue is this: insurance is not designed to eliminate that cost.

Solveglobal is.

We convert functional loss into business performance—offering:

  • Better movement and faster recovery

  • 10x workforce engagement

  • 30–40% net annual savings in direct MSD costs

Fewer claims. Lower costs. Higher trust.

Let’s turn MSDs from a liability into a performance advantage.

Solveglobal. Designed to fix what insurers won’t.

Get started with a no-nonsense Executive Briefing